Introduction {#s1}
============

During initiation of translation, a crucial step is the placement of the start codon and initiator tRNA in the P site of the ribosome ([@bib63]). In eukaryotes, initiation involves almost a dozen protein initiation factors (IFs), several of which are large multi-subunit complexes. A subset of IFs bind to the capped 5' end of a mRNA followed by recruitment of a 43S complex of the small subunit (with additional IFs). Subsequently, the resulting 48S complex scans along the mRNA to reach the start codon ([@bib3]; [@bib26]). The complexity of initiation in eukaryotes is used by cells to regulate translation ([@bib28]). However, viruses, which rely on the host machinery to translate their genomes, often target initiation to hijack host ribosomes ([@bib27]; [@bib79]). One strategy employed by viruses relies on the use of structured sequences in their mRNA that allow them to bypass many or all aspects of canonical initiation ([@bib48]; [@bib81]; [@bib33]). These structured RNA sequences, termed IRES (for [I]{.ul}nternal [R]{.ul}ibosomal [E]{.ul}ntry [S]{.ul}ite) elements, play a critical role in translation of their messages ([@bib48]; [@bib27]).

Viral IRES sequences can be classified according to their level of dependence on IFs ([@bib20]). Type IV IRESs form a homogenous class of viral RNAs, which completely dispense with the requirement for any IFs and thus are able to directly recruit and assemble a translating 80S ribosome by themselves. These IRESs are typically found in the intergenic region (IGR) of a family of + sense RNA viruses called *Dicistroviridae* hence they are also known as IGR-IRES ([@bib81]; [@bib60]). Extensive biochemical and structural characterization of these IRES sequences has provided a detailed picture on how they work at a molecular level. The approximately 190 nucleotide sequence folds into a compact, well-defined three-dimensional structure making use of three internal pseudoknots (PKI-III, [Figure 1](#fig1){ref-type="fig"}) ([@bib14]; [@bib15]; [@bib50]; [@bib64]; [@bib49]). Two of these pseudoknots (PKII and PKIII) and accessory sequences, fold into a compact domain following a scheme also seen in other structured RNAs ([@bib33]; [@bib7]). As a result, two stem loops (SL-IV and SL-V) are exposed and are responsible for the bulk of interactions with the small ribosomal subunit ([@bib19]; [@bib64]; [@bib65]). Two additional regions of the IGR-IRES are functionally relevant: the L1.1 region, responsible for the interaction with the L1 stalk of the large ribosomal subunit and PKI. This latter pseudoknot, a structural mimic of a canonical tRNA-mRNA interaction, is responsible for the correct positioning of the viral RNA in the decoding center of the small ribosomal subunit, and is recognized by the ribosome in the same way as a cognate mRNA-tRNA pair ([Figure 1A and D](#fig1){ref-type="fig"}, [@bib19]; [@bib15]).10.7554/eLife.13567.002Figure 1.Interaction of PKI of CrPV-IRES in the 40S mimics decoding.(**A**) Schematic representation of the type-IV IRES, colored according to different structural motifs. (**B**) Overall view of the interaction of the CrPV-IRES PKI (colored as in (**A**) in the context of the small ribosomal subunit (40S, yellow). On the left, experimental density is shown in the same orientation as on the right, where the final refined model is depicted. (**C**) Schematic view of PKI with main components labelled. (**D**) Space-filling models for the base pairs established between the anticodon and codon mimics of PKI (BP1-3) as well as the adjacent base pair (BP4).**DOI:** [http://dx.doi.org/10.7554/eLife.13567.002](10.7554/eLife.13567.002)10.7554/eLife.13567.003Figure 1---figure supplement 1.EM image processing workflow for the CrPV-IRES/40S data.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.003](10.7554/eLife.13567.003)10.7554/eLife.13567.004Figure 1---figure supplement 2.Quality of maps and models.(**A**) Fourier shell correlation (FSC) of two independent half-maps for the complex CrPV-IRES/40S from the final refined class of particles. (**B**) FSC calculated for the refined model and the final map (black line). For cross-validation, the FSC calculated against a model refined with a half map (red line) is compared with the FSC calculated with the half map not included in the refinement (blue line). The overlapping of both lines provides evidence for the absence of overfitting in the refined model. (**C**) Unsharpened map colored according to the computed local resolution for the final map for the CrPV-IRES in the binary CrPV-IRES/40S complex. (**D**) Refined model of CrPV-IRES colored according to the atomic B-factor values (blue low, red high). (**E**) Fourier shell correlation (FSC) of two independent half-maps for the complex 80S/CrPV-IRES/eEF2 from the final refined class of particles. (**F**) FSC calculated for the refined model and the final map (black lane). Cross-validation by comparing the FSC calculated against a model refined with a half map (red line) and the FSC calculated with the half map not included in the refinement (blue line). (**G**) Unsharpened map colored according to the computed local resolution for the final map for the CrPV-IRES and eEF2. (**H**) Refined model of eEF2 coloured according to the atomic B-factor values (blue low, red high).**DOI:** [http://dx.doi.org/10.7554/eLife.13567.004](10.7554/eLife.13567.004)10.7554/eLife.13567.005Figure 1---figure supplement 3.Experimental electron density examples.(**A**) CrPV-IRES PKI densities obtained for the CrPV-IRES/40S complex (left) and for the 80S/CrPV-IRES/eEF2 complex (right). Partial density was observed for the variable loop of PKI (VRL) in the complex with the 40S ribosomal subunit. (**B**) Experimental density observed for the three decoding base pairs of the CrPV-IRES (BP1-3) and the adjacent base pair (BP4) in the 40S/CrPV-IRES complex. CrPV-IRES bases are depicted green and the 40S components of the decoding center yellow. (**C**) Electron density observed for the rRNA component of the L1-stalk in the displaced conformation as observed in the 80S/CrPV-IRES/eEF2 complex. (**D**) Electron density for the decoding bases A1753 and 1754 in a retracted position in the 80S/CrPV-IRES/eEF2 complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.005](10.7554/eLife.13567.005)

Early cryo-EM reconstructions of binary IGR-IRES/ribosome complexes showed how the IGR-IRES is inserted in the intersubunit space of the ribosome, contacting the regions predicted by mutagenesis assays ([@bib64]; [@bib65]; [@bib32]). More recent higher-resolution cryo-EM studies showed that the IRES coexists in equilibrium between canonical and rotated states of the ribosome ([@bib19]; [@bib34]). The presence of PKI in the A site is consistent with evidence that translocation of the IRES is required to bring the first codon of the mRNA into the A site and allow delivery of the first animoacyl tRNA ([@bib83]; [@bib87]). It also implies that translation of these mRNAs begins in the middle of what is normally the elongation cycle, thus bypassing normal initiation completely and avoiding any regulation over initiation.

Translocation is defined as the concerted movement of tRNAs and mRNA with respect to the ribosomal subunits ([@bib58]; [@bib77]; [@bib42]). Upon the acceptance of a cognate tRNA on the A site, peptidyl transfer from the peptidyl tRNA in the P site to the newly accepted aminoacyl tRNA on the A site occurs spontaneously and allows the ribosome to reach an intermediate state of translocation characterized by hybrid A/P and P/E states of the tRNAs and intersubunit rotation ([@bib40]; [@bib21]; [@bib2]). This intermediate state is in equilibrium with the original canonical conformation ([@bib11]). The GTPase elongation factor EF-G in bacteria stabilizes the intermediate state and catalyzes the next step of the process, which involves movement of the mRNA and tRNAs with respect to the small subunit ([@bib40]; [@bib57]; [@bib67]). Both EF-G and its eukaryotic counterpart eEF2 exhibit a high degree of sequence homology and hydrolyze one molecule of GTP into GDP per translocation cycle. The result of translocation is the movement of the A-site tRNA to the P site and the P-site tRNA to the E site and its subsequent dissociation from the ribosome. Translocation results in an empty A site that can bind the next incoming aminoacyl tRNA. Frameshifting is avoided by coordinate movement of mRNA and tRNAs, which is facilitated by the maintenance of base-pairing interactions between the anticodon stem loops (ASL) of the tRNAs and the mRNA codons during translocation.

Recent structural studies have complemented previous detailed biochemical and single molecule fluorescence studies and shed unprecedented light on the structural nature of various steps of translation elongation and the role of EF-G/eEF2 ([@bib24]; [@bib75]; [@bib51]; [@bib12]; [@bib86]). More recently, structures of EF-G/ribosome complexes with both A- and P-site tRNAs have also been determined ([@bib12]; [@bib86]; [@bib53]). These structures reveal how bacterial EF-G binds to a rotated state of the ribosome, inducing an extra degree of rotation while domain IV of EF-G contacts the tRNA in a hybrid ap/P configuration. In this hybrid state, the tRNA has its anticodon at a position intermediate between the canonical A and P sites in the small subunit while its aminoacyl end is in the P site of the peptidyl transferase center in the large subunit ([@bib54]).

Even though there are many similarities between bacterial and eukaryotic translocation, some important features are unique to eukaryotes. For example, a conserved histidine residue (H699 in yeast, H719 in mammals) in a loop at the tip of domain IV of eEF2 is post-translationally modified to diphthamide (DPH) ([@bib61]). The diphthamide modification, which requires the activity of seven gene products, is conserved in eukaryotes and archaea ([@bib61]), but its precise function is unclear. To date, the key feature of diphthamide is that it renders eEF2 susceptible to mono-ADP ribosylation and inactivation by diphtheria toxin, *Pseudomonas* exotoxin A, and cholera toxin ([@bib61]; [@bib47]). Despite uncertainty regarding the cellular function of diphthamide, yeast strains lacking the diphthamide modification enzyme DPH2 display altered levels of frameshifting on the programmed -1 frameshift site from the yeast L-A virus, indicating that diphthamide contributes to fidelity of translation elongation in vivo ([@bib46]).

Type IV IRES--mediated peptide synthesis requires two prior translocation events: first, movement of the IRES to translocate PKI from the A to the P site, and a second translocation that moves PKI from the P to the E site while simultaneously translocating the first aminoacyl tRNA from the A to the P site (without peptidyl transfer). A precise understanding of how eEF2 works in the context of a ribosome programmed with a type IV IRES is thus needed to fully understand how these IRESs function. Because the IRES mimics tRNAs in the ribosome, such an understanding will also shed light on the role of eEF2 in canonical translocation with tRNAs.

This work addresses two questions. Firstly, it describes the detailed structure of the type IV Cricket Paralysis Virus IRES (CrPV-IRES) bound to the small ribosomal subunit (40S), and how it primes the recruitment of the large subunit in order to assemble a translationally competent 80S. Secondly, the structure of eEF2 with a ribosome-IRES complex in an intermediate state provides insights into eEF2's role in both IRES and canonical translocation.

Results {#s2}
=======

CrPV-IRES interaction with the isolated 40S ribosomal subunit {#s2-1}
-------------------------------------------------------------

The first step in translation of an mRNA with a type IV IRES is the recruitment of the small ribosomal subunit (40S) ([@bib28]). To gain insights into the interactions that make this possible, we assembled binary CrPV-IRES/40S complexes for analysis by cryo-EM. Previous data at low resolution had shown the stability of this binary complex ([@bib65]). A full dataset was collected on a Titan Krios microscope equipped with a Falcon-II direct detector. Given the high degree of compositional as well as conformational heterogeneity present in the sample, extensive classification using a new sorting procedure involving masking and background subtraction (doi: <http://dx.doi.org/10.1101/025890>) was essential to classify homogenous populations ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. A final subset of 54,561 particles produced a homogenous map with an overall resolution of 3.8 Å ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}); however, as previously noted ([@bib64]; [@bib87]), many CrPV-IRES elements have a lower local resolution because they are more dynamic ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Careful analysis of the local resolution ([@bib35]) also showed a high degree of flexibility in regions of the IRES not directly involved in interactions with the 40S, such as L1.1 and L1.2. However, good density could be observed for the functionally relevant regions of the IRES responsible for its binding to the 40S (SL-IV and SL-V) as well as for PKI in the decoding center ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and [Videos 2](#media2){ref-type="other"}, [3](#media3){ref-type="other"} and [4](#media4){ref-type="other"} and [Table 1](#tbl1){ref-type="table"}).10.7554/eLife.13567.006Table 1.Refinement and model statistics for the final refined models.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.006](10.7554/eLife.13567.006)Data CollectionCrPV-IRES/40SCrPV-IRES/eEF2/80S Particles54,48137,844 Pixel size (Å)1.341.34 Defocus range (µm)1.8-3.51.8--3.5 Voltage (kV)300300 Electron dose (e-/Å^2^)2531**Model composition** Non-hydrogen atoms79,660205,348 Protein residues4,82811,278 RNA bases1,7815,264**Refinement** Resolution used for refinement (Å)3.83.6 Map sharpening B-factor (Å^2^)-119.8-70.8 Average B factor (Å^2^)152.3141.16 MolProbity Clashscore97^th^ percentile97^th^ percentile MolProbity Score90^th^ percentile90^th^ percentile Average Fourier Shell Correlation (FSC~avg~)0.720.83**Rms deviations** Bonds (Å)0.00570.0072 Angles (˚)1.211.3**Ramachandran plot** Favored (%)84.1781.64 Outliers (%)4.44.63**RNA validation** correct sugar puckers (%)94.295.3 good backbone conformations (%)55.565.1Video 1.Video showing the movements of the CrPV-IRES induced by the binding of eEF2 in first translocation event.CrPV-IRES populates an intermediate state between the A site and the P site reminiscent of a ap/P like state. In order to highlight the movement of CrPV-IRES the motions of the 40S ribosomal subunit in relation to the 60S ribosomal subunit have not been shown.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.007](10.7554/eLife.13567.007)10.7554/eLife.13567.007Video 2.Video showing experimental density obtained for PKI (green) and the decoding elements of the 40S (yellow) in the CrPV-IRES/40S complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.008](10.7554/eLife.13567.008)10.7554/eLife.13567.008Video 3.Video showing experimental density obtained for SL-IV (green) of the CrPV-IRES and ribosomal proteins uS11 (yellow) and uS7 (brown) of the 40S in the CrPV-IRES/40S complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.009](10.7554/eLife.13567.009)10.7554/eLife.13567.009Video 4.Video showing experimental density obtained for SL-V (green) of the CrPV-IRES and ribosomal proteins uS7 (yellow) and eS25 (brown) of the 40S in the CrPV-IRES/40S complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.010](10.7554/eLife.13567.010)10.7554/eLife.13567.010

Recent studies of canonical eukaryotic translation initiation suggest an important role for the dynamics of the head of the 40S to correctly position the Met-tRNA~i~ in the P site ([@bib37]; [@bib8]). Interestingly, the CrPV-IRES appears to have restricted the conformational flexibility of the 40S head. This is mainly accomplished by insertion of SL-IV and V of the IRES in the cleft formed between the head and the body of the 40S, as previously seen in the context of the pre-translocation binary complex CrPV-IRES/80S ([Videos 3](#media3){ref-type="other"} and [4](#media4){ref-type="other"}, [@bib19]).

With this conformation of the head, PKI is able to bind well to the decoding center, allowing for a detailed analysis of its contacts ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} and [Video 2](#media2){ref-type="other"}). While the PKI contacts show marked similarity with canonical decoding, additional features distinguish PKI. Previous mutagenesis studies established the essential role of the correct base pairing of the tRNA/mRNA mimicry domain of type IV IRESs ([@bib32]; [@bib29]). Watson-Crick geometry between these bases of PKI is therefore essential to induce a conformation of the decoding center similar to that in decoding with tRNA ([Figure 1B,C and D](#fig1){ref-type="fig"}, [@bib45]). Briefly, the conserved adenines 1753 and 1754 (1492 and 1493 in *E. coli*) project outwards from helix 44 (h44) to interact through A-minor motifs with the nucleotides forming base pairs (BP) 1 and 2 of the codon/anticodon minihelix ([Figure 1C](#fig1){ref-type="fig"}). Accessory elements from other ribosomal components including G576 (G530 in *E. coli*), C564 (C518 in *E. coli*) and residues from uS12 (P64 and S66, \[P48 and S50 in *E. coli*\]) assist in monitoring the shape of BP1 and BP2, and less stringently of BP3 (the wobble position, [Figure 1D and E](#fig1){ref-type="fig"}). We also observed an additional base pair between position 1 of the first translated codon and the ribosomal base C1273 (C1054 in *E. coli*; termed BP4, [Figure 1B,D and E](#fig1){ref-type="fig"}). In standard decoding, this ribosomal base interacts with the anticodon nucleotide of BP3, whereas here a rotation of the base about its glycosidic bond allows for a tight stacking interaction with one of the CrPV-IRES bases, redirecting C1273 towards the first base of the first coding codon of the CrPV RNA. All IGR-IRES sequences obtained to date encode a guanine residue at this position with the only exception being the PSIV-IRES ([@bib33]). This conservation suggests an important role of the additional base pair.

In addition to directing the synthesis of the viral structural protein ORF2, a sub-class of IGR-IRES elements synthetize a second polypeptide called Open Reading Frame x (ORFx), which is encoded in the +1 reading frame relative to ORF2 ([@bib55]). Although originally discovered and characterized in Israeli acute paralysis virus (IAPV), Kashmir bee virus (KBV), acute bee paralysis virus (ABPV), and Solenopsis invicta virus (SINV-1), ORFx translation was also recently reported for the CrPV-IRES sequence ([@bib80]). In order to select an open reading frame, PKI actively assists in presenting the adjacent first codon in a proper conformation in the A site to the first incoming aminoacyl-tRNA. Given the dynamic nature of PKI, its ability to direct initiation of ORF2 or alternatively ORFx could be linked to interactions with ribosomal elements present in the A site. Thus, C1273 may represent an important regulatory element in the ribosomal A site that helps direct frame selection by type IV IRES elements.

In our previous reconstruction of a binary 80S/CrPV-IRES complex, the variable loop (VRL, [Figure 1](#fig1){ref-type="fig"}) connecting the mRNA-like fragment of PKI with the tRNA-like fragment was poorly ordered ([@bib19]). However, in the context of the 40S subunit, partial density for the VRL can be observed ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). Several studies have explored the structural and functional requirements of the VRL in type IV IRES-mediated translation ([@bib56]; [@bib59]). Interestingly, both the length and sequence of the VRL seem to be essential for the correct positioning of PKI in a productive conformation in the ribosomal A site, as well as for the translocation steps delivering PKI to the P-site ([@bib87]; [@bib59]). We speculate the VRL may have an important role in the initial stages of 40S recruitment by type IV IRESs, perhaps contributing additional anchoring points to the small subunit in the initial steps that could help in proper positioning of PKI. Whether this initial placement of PKI (assisted by the VRL) is related to the early events of frame selection by type IV IRESs will require further investigation.

Overall architecture of a complex of CrPV-IRES with the ribosome and elongation factor eEF2 {#s2-2}
-------------------------------------------------------------------------------------------

After recruitment of the large ribosomal subunit (60S), the CrPV-IRES/80S complex oscillates between two states of inter-subunit rotation, emulating a canonical pre-translocation complex after peptidyl transfer and prior to translocation ([@bib19]; [@bib34]). In this state, PKI remains anchored to the A site of the small subunit and the L1.1 segment couples the rotation of the small subunit with the movement of the L1 stalk of the 60S. In order to allow the first aminoacyl tRNA to be delivered to the A site, PKI has to be translocated to the P site, in a step catalyzed by eEF2. To gain insight into this process, we assembled a pre-translocation complex with CrPV-IRES and 80S, which was subsequently incubated with eEF2 complexed with the non-hydrolysable GTP analog 5\'-guanylyl-methylene-bis-phosphonate (GDPCP). This enabled us to trap the pre-translocation complex without the use of any antibiotics.

A large dataset was collected using a FEI Polara microscope equipped with a Falcon-III direct detector. Several rounds of classification in Relion ([@bib62]) were needed to identify a class of particles consisting of the entire complex that produced a map with an overall resolution of 3.6 Å ([Figure 2](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Clear density for eEF2 was visible ([Video 5](#media5){ref-type="other"}), especially for domains G, III, IV and V as well as for the CrPV-IRES ([Figure 1---figure supplement 2D--G](#fig1s2){ref-type="fig"}).10.7554/eLife.13567.011Figure 2.Conformational changes in the complex of CrPV-IRES with the 80S ribosome and eEF2.(**A**) Overview of the complex with the large ribosomal subunit (60S) depicted in blue, the small ribosomal subunit (40S) yellow, the CrPV-IRES green and the eEF2 in red. CrPV-IRES and eEF2 are represented as cartoon models inside the corresponding semi-transparent computed molecular surfaces. (**B**) Superposition of low-pass filtered (8Å) volumes from a front view of the 40S showing an additional \~3º rotation induced in the small subunit by eEF2 binding (yellow) when compared with the rotated state without eEF2 (violet, EMDB-2603). No swivelling of the 40S-head was observed. (**C**) Additional displacement of the L1 stalk induced by the binding of eEF2. The RNA component of the L1 stalk in the present structure with eEF2 (blue), the rotated state of the complex without eEF2 (violet; PDB 4V92), and in a complex with tRNAs in the hybrid state (orange; PDB-ID 4V9H).**DOI:** [http://dx.doi.org/10.7554/eLife.13567.011](10.7554/eLife.13567.011)10.7554/eLife.13567.012Figure 2---figure supplement 1.EM image processing workflow for the 80S/CrPV-IRES/eEF2-GDPCP data.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.012](10.7554/eLife.13567.012)Video 5.Video showing experimental density obtained for eEF2 (red ribbon) in the 80S/CrPV-IRES/eEF2 complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.013](10.7554/eLife.13567.013)10.7554/eLife.13567.013

The overall conformation of the complex exhibits an additional rotation of the 40S subunit with respect to the 60S of approximately \~3°, when compared with the rotated state previously published without eEF2 ([Figure 2A--B](#fig2){ref-type="fig"}). Thus, the binding of eEF2 in the GTP form induces an extra rotation of the small subunit as in canonical tRNA translocation ([@bib12]). However, the L1 stalk is \'pushed\' in the opposite direction relative to canonical translocation ([@bib75]), adopting a displaced position that is wider than the widest displacement seen in the rotated form of the CrPV-IRES/80S complex ([Figure 2C](#fig2){ref-type="fig"}, [Figure 1---figure supplement 3C](#fig1s2){ref-type="fig"}, [Video 1](#media1){ref-type="other"}).

CrPV-IRES conformation with PKI in an ap/P-like state {#s2-3}
-----------------------------------------------------

Translocation is a complex process, involving several orchestrated steps of subunit rotation, tRNA/mRNA movements, and 40S head swivelling ([@bib78]; [@bib18]). Structural studies by cryo-EM as well as X-ray crystallography have identified translocation intermediates where the small subunit can be found in several different degrees of rotation along with distinct conformations of the head ([@bib51]; [@bib54]). These movements are coupled to the movements of the tRNAs from the A to the P and finally to the E site, with intermediate \'hybrid\' states along the way. A useful nomenclature has been coined in order to reflect the diversity of states ([@bib54]). Thus, an ap/P state specifies a tRNA in transit from a canonical A/A state to a canonical P/P state with its anticodon stem-loop (ASL) between the A and P sites in the small subunit, while the CCA-peptidyl end has reached the P-site on the large subunit. This state was described by cryo-EM at \~8 Å resolution ([@bib12]; [@bib53]). Subsequently a tRNA that is intermediate in both the small and large subunits was seen by X-ray crystallography ([@bib86]). Because PKI mimics an A-site tRNA, the structure here allows us to observe high-resolution details of eEF2 in the A site of the small subunit before translocation.

The overall conformation of the CrPV-IRES in the presence of eEF2-GDPCP is shown in [Figure 3](#fig3){ref-type="fig"} and [Video 1](#media1){ref-type="other"}. A superposition of the IRES with the positions of tRNAs in their canonical states highlights a displacement of PKI due to the interaction with domain IV of eEF2. The ASL-like element of PKI is pushed into a position in-between the A and P sites of the small subunit, reminiscent of an ap/P state ([Video 1](#media1){ref-type="other"}). Additionally, a superposition of the CrPV-IRES in the ternary CrPV-IRES/eEF2-GDPCP/80S complex with the conformation adopted in the canonical, CrPV-IRES/80S binary complex (excluding PKI in the superposition) reveals a displacement of the ASL-like element of PKI of approximately 10 Å ([Figure 3C](#fig3){ref-type="fig"}). A comparison of the position of PKI in the CrPV-IRES/40S complex described previously with the position adopted by this pseudoknot in the pre-translocated state, in the CrPV-IRES/eEF2-GDPCP/80S complex described here as well as in the final post-translocated state ([@bib41]) is shown from a top view in [Figure 3D](#fig3){ref-type="fig"}. In this view, it can clearly be seen that in this intermediate, pre-translocated, state, interactions with domain IV of eEF2 induce PKI to adopt an ap/P state.10.7554/eLife.13567.014Figure 3.CrPV-IRES conformation induced by the binding of eEF2.(**A**) Overview of the complex with the area of interest highlighted. (**B**) Superposition of the CrPV-IRES (green) with tRNAs in canonical configurations (grey, PDB-ID 2WDG). Ribosomal sites A, P and E are indicated to show how the ASL-like element of the IRES PKI occupies a position between the A and P sites as it interacts with domain IV of eEF2 (red). (**C**) Relative displacement of PKI in a comparison of the conformation in the present reconstruction (green) with the one adopted in the CrPV-IRES/80S complex (grey). CrPV-IRES superposition has been computed excluding PKI. (**D**) View down the axis of the PKI stem in the CrPV-IRES/40S complex (top-left), in the pre-translocated CrPV-IRES/80S complex (top-right [@bib19]), in the 80S/CrPV-IRES/eEF2 complex (bottom-right) and finally, in the post-translocated 80S/CrPV-IRES complex (bottom-left, adapted from [@bib41]). Ribosomal sites A and P are depicted as dotted lines. The CrPV-IRES PKI (green) is inserted in the A-site in the isolated interaction with the 40S (yellow) as well as in the pre-translocated 80S/CrPV-IRES complex. The interaction with domain IV of eEF2 (red) displaces it towards the P site so it occupies an intermediate position between the A and P sites.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.014](10.7554/eLife.13567.014)

Interaction of domain IV of eEF2 with PKI and implications for translocation {#s2-4}
----------------------------------------------------------------------------

Domain IV of EF-G is important for its function, since a mutant EF-G lacking the domain is still able to bind to the ribosome, but is unable to catalyze translocation ([@bib57]). In the present structure, we observed clear density for domain IV of eEF2, and we were able to model its interaction with PKI ([Figure 4](#fig4){ref-type="fig"}, [Video 5](#media5){ref-type="other"}). Domains III and V of eEF2 solidly anchor the factor to the ribosome through interactions with ribosomal proteins uS12 and uL11 in the 40S and 60S subunits, respectively ([@bib10]). These interactions help position eEF2 such that two loops at the tip of domain IV contact PKI ([Figure 4](#fig4){ref-type="fig"}, [Video 6](#media6){ref-type="other"}). The loop comprising residues 579 to 584 comes close to the major groove of the ASL-like motif of PKI ([Figure 4B--C](#fig4){ref-type="fig"}). Residues P580 and H583 establish a tight stacking interaction allowing for a sharp turn of the polypeptide chain. At the tip of the bend, K582 is projected outwards to interact with the phosphate of nucleotide 6189 of PKI.10.7554/eLife.13567.015Figure 4.Interactions of PKI of CrPV-IRES with domain IV of eEF2.(**A**) Overview of the PKI-eEF2 interaction. The five domains of eEF2 are indicated. (**B**) Experimental density for the two loops at the tip of domain IV of eEF2 interacting with PKI. (**C**) Upper loop of eEF2 (residues 579 to 584) implicated in the interaction with PKI. P580 and H583 of eEF2 closely pack together through a stacking interaction to position K582 within interacting distance of the phosphate group of G6189 of the CrPV-IRES. (**D**) Residues 694--700 in the second loop making direct contacts with PKI. The diphthamide modification of H699 packs against the sugar moiety of G6189. Other residues of this loop such as H694 are also involved in direct contacts with PKI. (**E**) Retracted position adopted by the decoding bases A1753 and A1754 (A1492 and A1493 in *E. coli*) in the CrPV-IRES-eEF2-80S complex. (**F**) The extended conformation of these bases in which they are flipped out of helix 44 as would be seen during decoding or aminoglycoside binding would result in a clash with the tip of eEF2. The small ribosomal subunit components are coloured grey.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.015](10.7554/eLife.13567.015)Video 6.Video showing experimental density obtained for PKI (green) and domain IV of eEF2 (red) in the 80S/CrPV-IRES/eEF2 complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.016](10.7554/eLife.13567.016)10.7554/eLife.13567.016

The second loop of eEF2 directly involved in the interaction with PKI encompasses residues 694 to 700 ([Figure 4D](#fig4){ref-type="fig"}). In our structure, H694 interacts with PKI while the diphthamide moiety (DPH) on H699 is closely packed against the sugar of nucleotide 6189 in the CrPV-IRES. The diphthamide appears to sterically prevent the rRNA decoding bases A1753 and A1754 from interacting with BP1 and BP2 of PKI, whose conformations were otherwise not altered upon binding of eEF2 ([Figure 4E and F](#fig4){ref-type="fig"}). The interaction between bases A1753 and A1754 and PKI, was seen in the binary CrPV-IRES/40S complex described above, and was maintained during recruitment of the 60S and the induction of the rotated state in the binary CrPV-IRES/80S complex before eEF2 binding. However, this interaction must be broken in order for PKI to translocate from the A to the P site of the 40S. In our structure of the eEF2-bound complex, clear density for these decoding bases was seen in a retracted position in helix 44 ( [Figure 1---figure supplement 3D](#fig1s3){ref-type="fig"} ). This suggests that H699, by competing for the binding to PKI with these bases, breaks their decoding interaction with BP1 and BP2. Diphthamide, by making additional stabilizing interactions with PKI facilitates this step. The disruption of the decoding interaction of the ribosomal bases by eEF2 provides an explanation for the well known inhibitory effect of aminoglycoside antibiotics on the action of EF-G and translocation ([@bib57]; [@bib70]). The binding of these antibiotics displaces the ribosomal decoding bases out from helix 44 (h44) ([@bib13]; [@bib44]). The antibiotics would thus prevent retraction of the bases into helix 44 upon EF-G or eEF2 binding, thereby precluding interactions of the factors required for their function as well as preventing the disruption of the decoding interactions that is a pre-requisite for translocation ([Figure 4E and F](#fig4){ref-type="fig"}).

In order to test whether diphthamide plays a role in CrPV-IRES function, we established an *in vitro* reconstituted translation system using reagents from yeast ([Figure 5A](#fig5){ref-type="fig"}) to monitor IRES-mediated synthesis of the tri-peptide Met-Phe-Lys (MFK). Whereas the CrPV-IRES initiates translation with Ala, a minimal CrPV-IRES RNA, encompassing residues 6027 to 6216, was designed to initiate translation with Met ([Figure 5B](#fig5){ref-type="fig"}) to facilitate detection of peptide products using \[^35^S\]Met and to enable direct comparison to peptide synthesis directed by the normal translation initiation pathway. As shown in [Figure 5C](#fig5){ref-type="fig"}, the WT CrPV-IRES readily directed the synthesis of MFK tripeptide (left panel). Previous studies using mammalian factors ([@bib30]) or yeast or mammalian *in vivo* assays ([@bib82]; [@bib74]) established the critical importance of BP1 and BP2 in PKI for IRES-directed translation. Mutation of CC to GG disrupting BP1 and BP2 likewise abolished peptide synthesis in our assays ([Figure 5C](#fig5){ref-type="fig"}, second panel). As an additional control, a model unstructured mRNA that avoids the requirement for translation factors that promote mRNA recruitment was used to assemble a canonical 80S initiation complex. Notably, assembly of this complex required initiation factors eIF1, eIF1A, eIF2, eIF5 and eIF5B ([@bib25]). These 80S complexes readily synthesized MFK ([Figure 5C](#fig5){ref-type="fig"}, fourth panel) with faster kinetics than observed with the CrPV-IRES ([Figure 5C](#fig5){ref-type="fig"}, right panel). When this same model mRNA was substituted for the CrPV-IRES RNA in reactions lacking initiation factors no peptide synthesis was observed ([Figure 5C](#fig5){ref-type="fig"}, third panel), confirming the unique property of the IRES to carry out initiation factor-independent translation.10.7554/eLife.13567.017Figure 5.Diphthamide modification on eEF2 promotes CrPV-IRES translation.(**A**) Scheme for in vitro reconstituted translation elongation assay with CrPV-IRES RNAs. (**B**) Diagram of the secondary structure of the 200-nt CrPV-IRES. The coding region of the RNA was altered to encode the tripeptide MFK as indicated. Red asterisks denote the site of the CC to GG mutation in BP1 and BP2 of PKI. (**C**) Electrophoretic TLC analysis of peptide products from elongation assays programmed with the CrPV-IRES (left panel), the CC to GG mutant CrPV-IRES (second panel), or a model unstructured 52-nt mRNA encoding MFK (third panel). In the fourth panel, the same 52-nt model mRNA was assembled on 80S initiation complexes using the canonical translation initiation factors. The identities of spots corresponding to free methionine (M), dipeptide MF and tripeptide MFK are indicated. The fraction of MFK synthesis in the reactions with the WT CrPV-IRES and the 80S initiation complex were fit to a single exponential equation and plotted on the right. (**D--E**) Fraction of MFK synthesis in elongation assays programmed with 80S initiation complexes (**D**) or CrPV-IRES (**E**) and using purified WT eEF2, unmodified eEF2 lacking diphthamide (Unmod), eEF2-P580H, or eEF2-H699N, as indicated. Results were plotted and fit to a single exponential equation, and observed rate constants and end levels are shown (note the different time scales for the plots). Errors are standard deviation from three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.017](10.7554/eLife.13567.017)

Having established an IRES-dependent in vitro translation system using yeast components, we next examined the impact of eEF2 mutations on CrPV-IRES function. Three eEF2 mutant proteins were purified for these assays. First, eEF2 lacking diphthamide was prepared from yeast lacking the *DPH2* gene required for the first step in diphthamide synthesis ([@bib61]; [@bib46]). Second, eEF2-P580H was designed to disrupt the first loop at the tip of domain IV (see [Figure 4B--C](#fig4){ref-type="fig"}). Third, eEF2-H699N was designed to eliminate the diphthamide modification of this residue and because previous studies indicated a role for this residue in translation elongation fidelity ([@bib46]). Consistent with the negligible growth defects under normal conditions in yeast strains lacking *DPH2* or expressing eEF2-H699N ([@bib46]), the eEF2 mutants functioned like WT eEF2 to promote MFK formation in reactions using 80S initiation complexes ([Figure 5D](#fig5){ref-type="fig"}). Thus, lack of diphthamide does not significantly impair eEF2 function in normal translation including the translocation events required for MFK formation. In contrast, unmodified eEF2 and the eEF2-P580H and eEF2-H699N mutants exhibited marked defects in MFK synthesis in assays directed by the CrPV-IRES ([Figure 5E](#fig5){ref-type="fig"}). Since the translocation events prior to the first peptidyl transfer represent key differences between the IRES and canonical pathways for MFK synthesis, diphthamide appears to be important for the non-canonical translocation of the CrPV-IRES prior to first peptide bond formation. The interaction of diphthamide with G6189 of BP1 in the codon-anticodon mimicking element of PKI and the steric obstruction of the rRNA decoding bases by diphthamide suggest that its primary function during normal translation may be to optimize efficiency and fidelity during translocation. Testing this idea will require detailed kinetic studies in a eukaryotic translation system using eEF2 with and without the diphthamide modification.

A high-resolution view of the eukaryotic GTPase center in an active state {#s2-5}
-------------------------------------------------------------------------

The translational GTPases including eEF2/EF-G, eEF1A/EF-Tu, eIF5B/IF-2, and eRF3/RF-3 assist the ribosome in progressing through the various steps of polypeptide synthesis ([@bib69]). All of these factors bind to the ribosome in an active conformation as a complex with GTP. Their binding to the ribosome is followed by hydrolysis of GTP to GDP and subsequent release of the factors from the ribosome. GTP hydrolysis is induced by conformational changes in the ribosome, which position the catalytic site of the factor close to the sarcin-ricin-loop (SRL) in the large subunit. Recent structures of the ribosome in complex with EF-Tu or EF-G bound to GDPCP during decoding or translocation, respectively, have shed light on the molecular details of GTPase activation ([@bib75]; [@bib51]; [@bib76]). In these structures, three flexible loops (P-loop, switch-I and switch-II) of the GTPase are organized around the GTP (GDPCP) molecule and a highly conserved histidine residue from the switch-II loop (H84 in *E. coli* EF-G) is coordinated to a water molecule close to the γ phosphate (reviewed in \[[@bib77]\]). The conformation of the histidine is stabilized by a universally conserved nucleotide in the sarcin-ricin loop (SRL). Recent biochemical and molecular dynamics studies support the idea that the catalytic center observed in these structures represents a GTPase-activated state ([@bib38]; [@bib1]; [@bib6]). However, in structures of both bacterial RF-3 and EF-G with the GTP analog GDPNP, the conserved histidine was observed in a conformation away from both the SRL and the γ phosphate of the GTP molecule ([@bib84]; [@bib85]), suggesting that not all GTP analogs behave in the same way and that some may resemble the GTP state less than others.

The GTPase center observed here ([Figure 6](#fig6){ref-type="fig"}, [Video 7](#media7){ref-type="other"}) agrees with earlier crystallographic results obtained on bacterial systems with GDPCP. Clear density for the P loop, switch I and switch II were visible in our map ([Figure 6A](#fig6){ref-type="fig"}, [Video 7](#media7){ref-type="other"}) including unambiguous density for the side chain of H108 (H84 in *E. coli*). Additionally, we were able to identify the key magnesium ions described as essential elements for the proposed universal mechanism of GTPase activation ([Figure 6A](#fig6){ref-type="fig"}, [Video 7](#media7){ref-type="other"}). Although the current structure is of a eukaryotic complex determined by cryoEM, the locations of the key magnesium ions and the overall conformation of the three loops implicated in GTPase activation appear to be conserved with those previously observed in crystallographic studies in bacterial systems ([Figure 6B--C](#fig6){ref-type="fig"}). This suggests that there is a common and possibly universal mechanism for the activation of translational GTPases by the ribosome, as previously proposed ([@bib76]).10.7554/eLife.13567.018Figure 6.The GTPase center of eEF2 is conserved with those of bacterial EF-G and EF-Tu.(**A**) The 80S/CrPV-IRES/eEF2 complex (left) with the inset on the right showing details around the the GTPase centre. Clear experimental density is seen for the GDPCP molecule, the eEF2 residues implicated in catalysis (histidine 108, valine 28), as well as putative magnesium ions (green) that were previously seen with bacterial complexes of GTPase factors. (**B**) The GTPase centre of eEF2 showing the conformation adopted by the P-loop, switch I and II of the eEF2 as well as the ribosomal elements from the sarcin-ricin loop (SRL, cyan). (**C**) Corresponding view of EF-G (colored) ([@bib75]) and EF-Tu (gray) ([@bib76]) bound to the bacterial ribosome.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.018](10.7554/eLife.13567.018)Video 7.Video showing experimental density obtained for the GTPase Center in the 80S/CrPV-IRES/eEF2 complex.GDPCP is depicted as grey sticks, eEF2 components are depicted red (switch I as cartoon, switch II as sticks, and P-loop as ribbons) and the sarcin-ricin loop of the 25S rRNA as cyan cartoon. Magnesium ions discussed in the text are represented as green spheres.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.019](10.7554/eLife.13567.019)10.7554/eLife.13567.019

Discussion {#s3}
==========

Type IV IRES sequences are able to fold independently into a compact structure in solution ([@bib14]). Their tertiary structure allows crucial elements of the IRES to interact with the small ribosomal subunit via a cluster of specific ribosomal proteins (eS25, S28, uS7 and uS11) ([@bib19]). This cluster is strategically located in the cleft between the head and body of the 40S. By placing the IRES elements SL-IV and SL-V in that cleft ([Figure 1](#fig1){ref-type="fig"}), the IRES is able to restrict the otherwise highly dynamic head of the small ribosomal subunit. The restriction on the mobility of the 40S head upon CrPV-IRES binding involves an entropic cost, which is likely balanced by the binding energy from interactions between the CrPV-IRES and the small subunit. This stabilization of the head is accompanied by the insertion of IRES element PKI into the decoding site of the small subunit. The tRNA/mRNA mimicry of this domain induces conformational changes similar to those in decoding, thereby anchoring PKI to the A site. The VRL element of PKI seems to be involved in this early event, as ordered density for a segment of this highly dynamic loop can be distinguished in our reconstruction. The stabilization of the head in an appropriate conformation for 60S binding provides a rationale for how the IRES promotes recruitment of the 60S subunit to form the 80S ribosome. By contrast, those elements of the CrPV-IRES not directly interacting with the 40S (for example, L1.1 and L1.2) are very flexible, and thus, could only be visualized at low resolution in our 40S reconstruction ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). In contrast, these elements, especially L1.1, become ordered upon recruitment of the large ribosomal subunit due to specific contacts, primarily with the L1-stalk ([@bib19]).

The conformation of the 40S head also seems to be restricted by the initiation machinery during delivery of canonical initiator tRNA to the 40S subunit in eukaryotes ([@bib37]; [@bib17]). Thus, type IV IRESs seem to exploit a feature of ribosomes that is also used in canonical initiation. Other IRESs, such as the type III HCV-IRES, seem to target the same cluster of small subunit ribosomal proteins as the CrPV-IRES ([@bib52]), suggesting that this may be a general mode of action of IRES sequences.

PKI is an independent domain of the type IV IRESs that mimics a tRNA anticodon stem-loop interacting with a codon ([@bib15]). This domain is not essential for the binding of the IRES to the small subunit, but it is required for priming the ribosome for elongation ([@bib29]). Previous structural studies in the context of the full (80S) ribosome have unambiguously established the positioning of this PKI in the decoding center in the A site of the small subunit ([@bib19]; [@bib34]). Following recruitment of the 60S, the resulting IRES/80S complex oscillates between ratcheted and canonical configurations. This ratcheting of the ribosome involves the classic anti-clockwise rotation of the 40S by approximately 5° ([Figure 7](#fig7){ref-type="fig"}, top). In this rotated state, which is similar to a canonical pre-translocation complex, the IRES mimics the hybrid states of tRNAs ([@bib2]; [@bib31]). During these fluctuations, PKI remains anchored to the decoding center of the A site of the 40S and SL-IV and V remain anchored to the ribosomal protein cluster previously described. GTP hydrolysis by eEF2 catalyzes translocation of PKI to the P site ([Figure 7](#fig7){ref-type="fig"}, right). Subsequent dissociation of eEF2 results in a vacant A site ([Figure 7](#fig7){ref-type="fig"}, bottom right) that can accept the first aminoacyl tRNA. A conformation of the IRES with PKI translocated into the P site has recently been characterized using a release factor bound to a stop codon in the A site ([@bib41]). In the translocated state, PKI occupies the P site, as expected, but critically, the connections of SL-IV and V with the cluster of ribosomal proteins in the small subunit are lost, leaving these IRES elements solvent exposed. In contrast, the other major anchoring point of the IRES to the ribosome, the L1.1 element (which interacts with the L1-stalk of the 60S), remains solidly in place; however, the stalk is displaced even further compared to its position in the rotated state of the binary IRES-80S complex. The post-translocated conformation of the IRES is characterized by PKI in the P site, SL-IV and V detached from the 40S, and the L1 stalk pushed further away. The entire IRES is rotated around its longitudinal axis when compared to the pre-translocated state ([Figure 7](#fig7){ref-type="fig"}, bottom-right). Interestingly, in the post-translocated state Muhs *et al* report partial density for the VRL, which is stabilized by interactions with the small subunit ([@bib41]). No density for this loop could be identified in our previous reconstruction of the pre-translocated state ([@bib19]) or in the intermediate state of translocation with eEF2-GPCP presented here. However, partial density could be identified in the CrPV-40S complex. Thus, it seems the VRL alternates between ordered/disordered conformations, possibly regulating the affinities of the compact folds of the IRES, like PKI, as previously suggested ([@bib59])10.7554/eLife.13567.020Figure 7.A model for initiation of translation by type IV IRESs.Starting from the bottom left, type IV IRESs are able to establish a stable binary interaction with the 40S through the IRES elements SL-IV and V. This interaction restricts the flexibility of the 40S-head in a conformation that both allows decoding of PKI and recruitment of the 60S subunit. Top: once the 60S subunit is recruited, the binary CrPV-IRES/80S complex oscillates between canonical and rotated states mimicking the hybrid states of tRNAs ([@bib19]; [@bib34]). Right: eEF2 in its GTP form binds to the rotated state and induces an extra \~3 degree of rotation of the 40S. This extra rotation results in the IRES interacting with the L1 stalk of the 60S in a wider conformation. Domain IV of eEF2 contacts PKI of the IRES and stabilizes it in an intermediate ap/P-like state. Bottom, post-translocated state ([@bib41]): GTP hydrolysis results in conformational changes in eEF2 and the ribosome, the translocation of PKI in the P site, breaking of the original contacts of the IRES elements SL-IV and V with the 40S, and release of eEF2. In order for the IRES to adopt such a conformation, a rotation along its longitudinal axes is necessary.**DOI:** [http://dx.doi.org/10.7554/eLife.13567.020](10.7554/eLife.13567.020)

To reach the post-translocated conformation, the IRES has to go through the intermediate state described here, which is stabilized by interaction with eEF2. In the complex with eEF2 and GDPCP, PKI makes a tight interaction with the tip of domain IV of eEF2 and is displaced towards the P site of the ribosome. The ASL-like segment of PKI is in a position and orientation reminiscent of a hybrid ap/P state ([Figure 3](#fig3){ref-type="fig"}). The whole ribosome adopts a rotated configuration with an additional \~3º anti-clockwise rotation of the small subunit when compared with the rotated state of the binary IRES-80S complex. This extra rotation caused by the binding of eEF2 is also a feature of canonical translocation with tRNAs ([@bib12]). However, unlike the case of canonical translocation, L1 is not stabilized in an inward conformation but instead is displaced outward compared to the binary IRES-80S complex and is very similar to the post-translocated state. Thus, the additional rotation of the 40S subunit, induced by the binding of eEF2 in its active state, forces the IRES to \'push\' the L1-stalk to its widest displacement while maintaining the interactions of SL-IV and V with the small subunit. The displaced location of the L1-stalk seems to be compatible with a post-translocated state of the IRES as well as with a fully rotated conformation of the 40S in the presence of CrPV-IRES and eEF2-GPDCP. Whether these wide conformations of the L1-stalk are available for normal translocation with tRNAs or they represent a specific state induced solely by IRES sequences remains an open question to be further investigated. Presumably, after GTP hydrolysis and the accompanying conformational changes (namely swiveling of the 40S head plus back-rotation of the 40S subunit ([@bib54]), PKI reaches the P site. Thus, hydrolysis of GTP by eEF2 enables disruption of the interactions of SL-IV and V with the small subunit allowing PKI to reach the P-site. Following this initial translocation, the ribosome is in a state primed for elongation ([Figure 7](#fig7){ref-type="fig"}).

Our structure of the CrPV-IRES/eEF2-GPDCP/80S complex presents the first images of eEF2 docked on the ribosome with an authentic translocation substrate. Previous cryo-EM studies of yeast eEF2/80S complexes have suggested alternate roles for diphthamide. Based on the structure of an eEF2/80S complex with modeled tRNAs in the A and P sites, Spahn *et al.* proposed that diphthamide was positioned near the codon:anticodon duplex of the A-site tRNA, and that it might functionally replace the decoding bases (*E. coli* A1492/A1493) to stabilize the codon-anticodon pairing during translocation ([@bib66]). In a subsequent study employing ADP-ribosylated eEF2, it was proposed that domain movements in eEF2 that accompany GTP hydrolysis cause release of the codon:anticodon duplex from the decoding bases during translocation ([@bib73]). More recent structures of eEF2/80S ribosome complexes from humans and *Drosophila* lacked A- and P-site tRNAs and instead contained the yeast Stm1-like serpine 1 mRNA-binding protein 1 (SERBP1) snaking through the mRNA channel and A and P sites of the ribosome. In these latter structures diphthamide adopted two positions: either engaging helix 44 near the decoding bases or engaging SERBP1 in the mRNA channel ([@bib5]). Diphthamide is not essential for yeast cell growth. However, the structure suggests that it additionally stabilizes the interaction of the tip of domain IV with the codon-anticodon interaction, which is presumably maintained during translocation from the A to the P site. This interaction of domain IV would compete with the interaction of the ribosomal decoding bases that also interact with the codon:anticodon duplex in the A site, suggesting how it would facilitate breaking the decoding interactions as a prelude to translocation. A reduction in the strength of the interaction of domain IV with the codon-anticodon helix could explain the enhanced -1 programmed ribosomal frameshifting observed in yeast or mammalian cells when eEF2 lacks the diphthamide modification ([@bib46]; [@bib36]). We propose that the diphthamide modification enhances the fidelity or efficiency of ribosomal translocation and that the unique translocation steps of CrPV-IRES translation, which are uncoupled from peptide synthesis, renders CrPV-IRES translation hypersensitive to the loss of diphthamide ([Figure 5](#fig5){ref-type="fig"}).

The conformational dynamics of ribosomes play an essential functional role in normal translation. These include the inter-subunit rotation (also known as ratcheting), the swiveling of the head about the long axis of the small subunit, and the fluctuations of the L1-stalk correlated with tRNA in the E site. It has been proposed that these movements are part of the mechanism to harness the thermal energy of the environment and channel it towards the production of useful work ([@bib68]; [@bib22]). Type IV IRES sequences are able to use the intrinsic dynamic nature of the ribosome to assemble a translating 80S on their mRNA while avoiding the highly regulated step of normal initiation. We were able to visualize at high resolution an intermediate state of translocation in the CrPV-IRES/eEF2-GDPCP/80S complex. The binding of eEF2 in its active state stabilizes a distorted conformation of the IRES and an additional 3 degrees of rotation of the small subunit. Subsequently, the energy stored in this state could be used along with GTP hydrolysis to enable disruption of interactions present in the initial binding of the IRES to the small subunit, thereby allowing progression of PKI to the P site. The vacated A site is then able to bind the first aminoacyl-tRNA. In conclusion, this work sheds light on various aspects of type IV IRES and eEF2 structure and function during translocation, and provides further evidence for a universal mechanism for GTP hydrolysis by translational GTPases ([@bib76]).

Materials and methods {#s4}
=====================

Preparation of ribosomes {#s4-1}
------------------------

Ribosomes were purified from the *Kluyveromyces lactis* strain GG799 as described previously ([@bib19]). Cells were harvested in mid-log phase (OD~600~ of 2--4) and resuspended in 20 mM MES-KOH pH 6, 150 mM KCl, 150 mM K-acetate, 10 mM Mg^+2^-acetate, 1 mg/ml heparin, 0.1 mM PMSF, 0.1 mM benzamidine, 2 mM DTT. Cell pellets frozen in liquid nitrogen were mechanically disrupted by a blender. The lysate was thawed at 4°C and clarified by centrifugation for 20 min at 14,500 g. Ribosomes in the supernatant were pelleted through a 1M sucrose cushion in the same buffer for 4 hr at 45,000 rpm in a Ti45 rotor (Beckman Coulter, Jersey City, NJ). The pellets were resuspended in 20 mM MES-KOH pH 6, 50 mM KCl, 5 mM Mg^+2^-acetate, 0.1 mM PMSF, 0.1 mM benzamidine, 2 mM DTT, and incubated for 15 min with 1 mM puromycin on ice. The sample was loaded on a 10--40% sucrose gradient in the same resuspension buffer and centrifuged for 16 hrs at 28,000 rpm in a Ti25 zonal rotor (Beckman Coulter, Jersey City, New Jersey). For subunit purification, 80S ribosomes were exchanged into dissociation buffer (20 mM MES-KOH pH 6, 600 mM KCl, 8 mM Mg^+2^-acetate, 1 mg/ml heparin, 0.1 mM PMSF, 0.1 mM benzamidine, 2 mM DTT) before loading onto a sucrose gradient in the same buffer and centrifuged for 19 hr at 28,500 rpm in the Ti25 rotor. The 60S and 40S subunits were exchanged separately into reassociation buffer (10 mM MES-KOH pH 6, 10 mM NH~4~-acetate, 40 mM K-acetate, 8 mM Mg^+2^-acetate, 2 mM DTT), concentrated to 6 µM and stored at −80°C after being flash frozen in liquid nitrogen.

Preparation of CrPV IRES {#s4-2}
------------------------

The gene for wild-type CrPV-IRES, was chemically synthesized and cloned in the pUC19 vector flanked at the 5' by a T7 promoter sequence and an EcoRI cleavage site at the 3′. Standard in vitro transcription protocols were used for the production and purification of IRES RNA.

Purification of elongation factor eEF2 {#s4-3}
--------------------------------------

Elongation factor eEF2 was cloned with a in-frame fused N-terminal calmodulin-binding peptide from genomic DNA extracted from the *Saccharomyces cerevisiae* strain YAS-2488 and introduced into pUC18 vectors containing the expression cassette described previously ([@bib23]). These expression cassettes were transferred to pRS424 (eEF2) plasmids. BCY123 cells (*MAT*α *pep4::HIS3 prb1::LEU2 bar1::HIS6 lys2::GAL1/10-GAL4 can1 ade2 trp1 ura3 his3 leu2-3,112*) containing a target plasmid together with the alternative empty one, were grown on selective medium (lacking uracil and tryptophan) with 1% raffinose to *A*600 nm = 0.8--1.0. Protein expression was induced by the addition of galactose to the final concentration of 2% and cells were grown at 30°C for 12--16 hr. Cell pellets were resuspended in one volume of 2× CAL350 buffer (100 mM Tris-HCl pH 8.5, 500 mM NaCl, 4 mM CaCl2, 2 mM Mg-acetate, 2 mM imidazole, 20 mM 2-mercaptoethanol, 0.2% Igepal CA-630, EDTA-free protease inhibitor cocktail (Roche)), and frozen in liquid nitrogen. Solid-phase cell disruption was performed with freezer mill 6870 (SPEX CertiPrep), the crude extract was adjusted to pH 8 with Tris base and centrifuged at 48,000 *g* at 4°C for 30 min. The supernatant was incubated with calmodulin-sepharose (recombinant calmodulin coupled to cyanogen bromide-activated sepharose) overnight at 4°C. The resin was washed with CAL500W buffer (20 mM Tris-HCl pH 8, 500 mM NaCl, 2 mM CaCl2, 1 mM Mg-acetate, 1 mM imidazole, 10 mM 2-mercaptoethanol) and eluted with CAL500E buffer (20 mM Tris-HCL pH8.0, 500 mM NaCl, 2 mM EGTA, 1 mM Mg-acetate, 1 mM imidazole, 10 mM 2-mercaptoethanol). After dialysis against Low-Salt-dialysis buffer (20 mM Tris-HCl pH 7.2, 50 mM KCl, 10 mM NH~4~Cl, 1 mM MgCl~2~, 2 mM DTT) at 4°C, the samples were further purified by ionic exchange (Q-HP-sepharose colum) and gel filtration (sephacryl-S200). The running buffer for the final gel filtration step was 20 mM Hepes-KOH pH 7.45, 200 mM K-acetate, 10 mM NH~4~Cl, 1 mM MgCl~2~, 2 mM DTT). eEF2 eluted from the gel filtration step was concentrated to 3.7 µM, snap frozen in liquid nitrogen and stored at --80˚C.

A 5X molar excess of CrPV-IRES (850 nM) was mixed with the 40S subunit (170 nM) in a total volume of 40 µl and incubated for 2 min at 30˚C before the sample was cooled to 4˚C, diluted to 150 nM 40S, and used immediately to make cryo-EM grids.

For the 80S/CrPV-IRES/eEF2 complex, purified 60S ribosomal subunits (150 nM) were added to the previously described complex followed by a 2 minutes incubation at 30˚C. In parallel, purified eEF2 was incubated for 5 minutes at 30˚C with 1 mM GPDPC. In a final step, the CrPV-IRES/80S was combined with eEF2/GDPCP for a final incubation of 5 minutes at 30˚C and used immediately to make cryo-EM grids.

Electron microscopy {#s4-4}
-------------------

Aliquots of 3 µl of the CrPV-IRES/40S or CrPV-IRES/eEF2-GPPCP/80S at a concentration of 100--150 nM were incubated for 30 s on glow-discharged holey carbon grids (Quantifoil R2/2), on which a home-made continuous carbon film (estimated to be \~50 Å thick) had previously been deposited. Grids were blotted for 2.5 s and flash cooled in liquid ethane using an FEI Vitrobot. Grids were transferred to an FEI Titan Krios microscope for the CrPV-IRES/40S complex or to a Polara G3 microscope for the CrPV-IRES/eEF2-GPDCP/80S both operated at 300 kV. Defocus values in the final data sets ranged from 1.6--3.6 µm. Images were recorded in automatic mode using EPU software (FEI) on an back-thinned FEI Falcon II detector for the Krios dataset and in a Falcon-III for the Polara dataset at a calibrated magnification of 104478 (yielding a pixel size of 1.34 Å) as described previously ([@bib9]). All electron micrographs that showed signs of significant astigmatism or drift were discarded.

Analysis and structure determination {#s4-5}
------------------------------------

All reconstructions described were calculated using semi-automated image processing as outlined below. We used the swarm tool in the e2boxer.py program of EMAN2 ([@bib72]) for semi-automated particle picking. For our final data sets, we selected 190,895 particles from 1012 micrographs for the 80S/CrPV-IRES/eEF2 complex and 139, 957 particles for the 40S/CrPV-IRES complex from 998 images. Contrast transfer function parameters were estimated using CTFFIND ([@bib39]). All 2D and 3D refinements were performed using RELION ([@bib62]) and the model were manually adjusted to density using COOT ([@bib16]) and refined with REFMAC ([@bib43]).

Preparation of aminoacyl-tRNA for peptide formation assay {#s4-6}
---------------------------------------------------------

Yeast initiator tRNA~i~^Met^ was prepared by T7 in vitro transcription. As noted previously, in vitro transcribed tRNA~i~^Met^ lacking modified nucleotides readily functions in elongation (Astrom and Bystrom, Cell 1994. 79:535--546; Pestova and Hellen 2001. RNA 7:1496--1505; Pestova and Hellen 2003. Genes & Development 17:181--186). Yeast tRNA^Phe^ (Sigma) and tRNA^Lys^ (tRNAprobes, Texas) were obtained from commercial vendors.

The tRNA~i~^Met^ was aminoacylated using purified His-tagged *E. coli* MetRS. *E. coli* XL1 Blue cells (Agilent) carrying the MetRS expression plasmid pRA101 ([@bib4]) were grown in 500 ml LB medium containing 100 µg/ml ampicillin at 37°C to A~600~ = 0.5. Following addition of 0.2 mM IPTG the culture was incubated at 20°C for 14 hr. Following harvesting, the cell pellet was suspended in 20 ml lysis buffer (50 mM Tris-HCl \[pH 7.5\], 300 mM KCl, 6 mM 2-mercarptoethanol, and 10% glycerol) and cells were broken by sonication using a microtip (5 cycles of 30 s pulse followed by 30 s cooling at 4°C). The cell lysate was cleared by centrifugation at 27,000 x g for 30 min and then mixed gently with 1 ml Ni-NTA resin (Qiagen) at 4°C for 1 hr. The resin was transferred to a 1 ml disposable column (Qiagen), washed sequentially with 10 ml lysis buffer, 20 ml lysis buffer containing 20 mM imidazole, and then protein was eluted in 4 ml lysis buffer containing 250 mM imidazole. The elute was dialyzed overnight against 50 mM Tris-HCl (pH 7.5), 25 mM KCl, 10 mM MgCl~2~, 1 mM DTT and 10% glycerol. For aminoacylation of tRNA~i~^Met^, 5 µM tRNA~i~^Met^ was mixed with 2 mM ATP, 0.3 µM \[^35^S\]Met (Perkin Elmer), 10 mM MgCl~2~ and 1 µM MetRS in reaction buffer (100 mM HEPES-KOH \[pH 7.5\], 10 mM KCl and 1 mM DTT), and then incubated at 37C for 30 min. Typically, about 60% of tRNA~i~^Met^ was aminoacylated with \[^35^S\]Met.

The tRNA^Phe^ was aminoacylated using purified yeast PheRS. To prepare PheRS, the open reading frames (ORFs) of FRS2 and FRS1, encoding the α and β subunits of yeast PheRS, respectively, were cloned into the polycistronic expression vector pST39 ([@bib71]). First, an N-terminal His~6~-tagged version of the FRS2 and FRS1 open reading frames were cloned between the *Nde*I and *Bam*HI sites of the vector pET3a Trm, and then FRS2 was moved as an *Xba*I-*Bam*HI fragment to the expression vector pST39 generating the plasmid pC5105. Next, the FRS1 open reading frame was transferred on a *Bsp*EI-*Mlu*I fragment to pC5105 generating the plasmid pC5106. For purification of PheRS, *E. coli* strain BL21(DE3) pLys (Agilent) carrying pC5106 was grown in 500 ml LB medium containing 100 µg/ml ampicillin at 37°C to A~600~ = 0.5. Then, 0.2 mM IPTG was added and the culture was incubated at 25C for 16 hr. Following harvesting, the cell pellet was suspended in 20 ml lysis buffer (20 mM Tris-HCl \[pH 7.5\], 500 mM KCl, 5 mM MgCl~2~, 1 mM 2-mercaptoethanol, 10 mM imidazole and 10% glycerol), and PheRS was purified as described above for purification of MetRS. The final PheRS elute was dialyzed overnight against 20 mM Tris-HCl (pH 7.5), 150 mM KOAc, 2.5 mM MgO(Ac)~2~, 2 mM DTT and 10% glycerol.

To aminoacylate tRNA^Lys^, we first cloned N-terminal His~6~-tagged KRS1 (Lysyl-tRNA synthetase from *S. cerevisiae*) into pET3a between the *Nde*I and *Mlu*I restriction sites. For purification of LysRS, *E. coli* strain BL21(DE3) CodonPlus-RIL (Agilent) was transformed with pET3a-KRS1 and cells were grown in 250 ml LB medium containing 100 µg/ml ampicillin at 37°C to A~600~ = 0.5. Following addition of 0.5 mM IPTG the culture was incubated at 20°C for 16 hr. LysRS was purified as described above for the purification of PheRS. Aminoacylation of tRNA~Phe~ and tRNA~Lys~ were performed as described previously ([@bib25]).

Peptide formation assay {#s4-7}
-----------------------

CrPV IRES RNA (nts 6027--6216) was prepared by T7 in vitro transcription using standard protocol. The DNA template for the T7 in vitro transcription was:

[GGCGTAATACGACTCACTATA]{.ul}AGCAAAAATGTGATCTTGCTTGTAAATACAATTTTGAGAGGTTAATAAATTACAAGTAGTGCTATTTTTGTATTTAGGTTAGCTATTTAGCTTTACGTTCCAGGATGCCTAGTGGCAGCCCCACAATATCCAGGAAGCCCTCTCTGCGGTTTTTCAGATTAGGTAGTCGAAAAACCTAAGAAATTTA**[CC]{.ul}**T *ATG UUC AAA UAA* UCUCUC; with the T7 promoter underlined, residues 6214 and 6215 that form BP1 and BP2 in PKI and are mutated in the CC to GG mutation (see [Figure 5](#fig5){ref-type="fig"}) depicted in bold and underlined, and the nucleotides encoding M-F-K-Stop italicized.

Purified ribosomes and translation factors were prepared and in vitro reconstituted peptide formation assays were performed according to procedures described previously ([@bib25]) with some modifications. Briefly, 0.4 µM IRES RNA was mixed with 0.4 µM 40S and 60S subunits in 1X reaction buffer (30 mM HEPES-KOH \[pH 7.5\], 100 mM KOAc, 1 mM MgO(Ac)~2~, 1 mM spermidine, and 2 mM DTT) and incubated at 26°C for 5 min. An elongation mix (5 nM \[^35^S\]Met-tRNA~i~^Met^, 2 µM eEF1A, 0.4 µM eEF2, 1 μM eEF3, 0.5 µM aminoacyl tRNA, 1 mM GTP-Mg^2+^, and 1 mM ATP-Mg^2+^) in 1X reaction buffer was then added to start the reaction. Reactions were terminated and peptide products were monitored by electrophoretic thin-layer chromatography as described previously ([@bib25]). Likewise, peptide formation assays using canonical 80S initiation complexes were performed as described previously ([@bib25]). The fractional yield of peptides in each reaction at different times were quantified and fit using Kaleidagraph (Synergy Software) to the single first-order exponential equation A\[1 − exp(−*kt*)\], where A is the amplitude and *k* is observed rate constant.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Structural characterization of ribosome recruitment and translocation by a type IV IRES\" for consideration by *eLife*. Your article has been favorably evaluated by John Kuriyan as the Senior editor and three reviewers, one of whom, Sriram Subramaniam, is a member of our Board of Reviewing Editors, and another one is Dmitry Lyumkis.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The manuscript \"Structural characterization of ribosome recruitment and translocation by a type IV IRES\" is a follow-on manuscript to one published from the same research group in 2014 in Cell, titled \"Initiation of translation by Cricket Paralysis Virus IRES requires its translocation in the ribosome\". In the first manuscript, Fernandez et al. determined the structure of the yeast 80S ribosome bound to the CrPV-IRES, finding that it exists in a dynamic equilibrium between \"canonical\" and \"rotated\" conformations. In this second manuscript, Murray et al. determined the structure of the yeast 40S ribosomal subunit bound to CrPV-IRES and the structure of the full 80S complex bound to eukaryotic elongation factor 2 (eEF2). The 80S/CrPV-IRES/eEF2 (with the GTP analog GDPCP) represents a step further along the elongation translocation cycle of the ribosome, just prior to the \"post-translocated\" state. Overall, the authors have revealed two new structures that offer unique insights into the structure and function of the ribosome during the translocation cycle.

The reviewers raise a number of concerns that must be adequately addressed before the paper can be accepted. It should be possible for you to address these issues without additional experimental work.

Essential revisions:

A major concern is that interpretation of the structures is underdeveloped in light of what is known. What is disappointing is the lack of connecting the structure to mechanistic topics of general interest to the IRES community. But that requires a deeper and more insightful analysis than is present in the manuscript. Consistent with this, there are key references missing (including many recent ones) that must be considered in the analysis. Several examples are given below:

In the last paragraph of the subsection "CrPV-IRES interaction with the isolated 40S ribosomal subunit". It was not clear what in this analysis of the interactions between the base-pairs of the codon-anticodon interaction and the ribosome is different than what has been described in other structures, including Koh et al. (2014) PNAS 11:9139-44, and previous work by these same authors in Fernandez et al. (2014) Cell 157:823-31. Perhaps this higher resolution work refines those interactions or makes them more certain. If something is truly novel here, the authors need to point it out. Otherwise, focus on the more novel potential findings that may lead to new ideas.

One very interesting and novel finding is the base-pair between C1273 and the first nt in the first decoded codon. But, the authors leave it as perhaps contributing to a \"productive conformation in the decoding center.\" This is not tested experimentally. In fact, the potential of this nt to form a base-pair within the IRES itself has been linked to the ability of some type IV IRESs to initiate in an alternate reading frame, thus this observation may have very exciting implications for IRES regulation (References: Au et al. (2015) PNAS 112:E6446-55; Wang et al. (2014) PloS One 9:e103601; Ren et al. (2012) PNAS 109:E630-9; Ren et al. (2014) Nucleic Acids Res. 42:9366-82.) None of these references, all with direct relationship to this structure, are included. Here and in a few other places, the manuscript (as written) does not reflect the current state of the field.

A missed opportunity: the interactions between the highly conserved apical loops of SL IV and V are known to make critical interactions with eS5 and eS25, but no high-resolution information is known for these interactions. Resolving this key mystery that would be a major contribution. [Figure 7](#fig7){ref-type="fig"}/[Video 1](#media1){ref-type="other"} -- The text and the model in [Figure 7](#fig7){ref-type="fig"} describe SL IV and V as not changing position between the eEF2 unbound to bound state. But, the movie shows something very different. How does the IRES achieve this non-canonical binding and how do the interactions change as the IRES moves? Other than stating an observation about their global position and not much movement occurring, the authors leave this unexplored. The authors miss an opportunity to examine how the Type IV IRESs and possibly other IRESs use these interactions. This is particularly interesting give the literatures regarding eS25 is pretty much as a central player in translation from many IRESs (Thompson lab, in particular).

What is the VLR loop in PKI doing in this mid-translocating state and how does it compare to the pre- and post-translocated state? [Video 1](#media1){ref-type="other"} shows some new density appearing at the junction between PKI and PKII upon eEF2 binding. It looks like the authors have modeled it as part of PKI\'s VLR. It is hard to tell from the movie/any figures. Recent work implicates this loop in elongation factor 2 function -- Ruehle et al., (2015) *eLife* --, and it has been explored in manuscripts from the Jan lab. What it is this loop doing and contacting and does it explain this previous work? Are previous predictions about its possible role correct?

In the last paragraph of the subsection "Overall architecture of a complex of CrPV-IRES with the ribosome and elongation factor eEF2". The position of the L1 stalk is interesting, but this is left with no explanation of potential significance. What might this say about how the IRES works? It is left as just an observation with no context. L1 is well established as a key player in translocation, so what does this odd position suggest? How does this fit into the idea of allosteric communication between L1 and other parts of the ribosome and bound factors? Are eukaryotes just different and what we have learned from bacteria does not apply?

Can the authors say anything about conformational changes within the IRES, outside of PK I? Looking at some modeling from Yamamoto et al., 2007, it would seem the larger part of the IRES may need to move or change structure, a bit for PK I to shift to its new location with the elongation factor. Some discussion of the overall movement of the IRES, and mechanistic implications, is needed.

The position of PKI between the A and P sites was previously suggested or observed in the very first cryo-EM reconstructions of a type IV IRES bound to a ribosome (Spahn Lab). While this was of lower resolution, this previous observation should be acknowledged and discussed. The same is true of the conformational change in the 40S subunit that likely prepares it for 60S subunit binding.

In regard to the observations relating to the diphthamide modification: this is an interesting result and one that bears deeper discussion. The authors suggest that the diphthamide on allows IRES-specific manipulation of the translation machinery that promotes translocation. But the region of the IRES that diphthamide contacts is the *most* similar to a canonical ribosome substrate in the entire IRES, begging the question of why there would need to be an IRES-specific solution there. Furthermore, there is no discussion regarding what is known about how eEF2 contacts canonical tRNA substrates using this modification. Because ribosomal contacts must release the codon:anticodon minihelix in canonical initiation, and they can do so independently of the diphthamide modification ([Figure 5](#fig5){ref-type="fig"}), it suggests the ribosome already has mechanisms in place to do this that the IRES should be able to harness as well. If the authors are correct that the modification permits the first noncanonical translocation, would this suggest that there are other, endogenous messages that specifically need to use the diphthamide in a similar way (given its conservation energetic expense for the cell, 8 enzymes)?

Other important points:

The Discussion section seems to largely repeat what was stated in the Results, without adding much insight.

1\) [Figure 1](#fig1){ref-type="fig"} -- This is essentially the only place where the map of the 40S/CrPV-IRES structure is shown (except for the representation in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} for resolution estimation). The way that it is displayed does not allow the reader to see how complete the structure is, nor how well the model fits to the structure. In D, the authors are obviously using space-filled models for the interactions -- actual density for these regions would allow the reader to see if these models actually are supported by the data in those regions.

2\) [Figure 2](#fig2){ref-type="fig"} -- As with [Figure 1](#fig1){ref-type="fig"}, the size and method of displaying the model for the 80D/CrPV-IRES/eEF2 map and model does not allow the reader or reviewer to judge the quality of fit or completeness of the map. Is A the map or model? B appears to be much lower resolution; is this the map? The authors should clearly indicate what they are showing (and should show the density when possible).

3\) [Figure 3](#fig3){ref-type="fig"} --This is not well described; the authors need to find a better way to communicate what they are saying here.

4\) [Figure 4](#fig4){ref-type="fig"} -- As in other figures, when making claims about \"clear density\" (see subsection "Interaction of domain IV of eEF2 with PKI and implications for translocation", first paragraph) for side-chains, that clear density needs to be shown. The authors display models in B-D but no density. Also, figures in E and F are unclear: are these models? Density? Of what?

5\) [Figure 6](#fig6){ref-type="fig"} -- This is the only place in the text where density is shown, but the region being shown is unlabeled. Additional labels in 6A and 6C should be included for clarity. Also, B should show comparison density from that complex as well.

6\) The supplemental movie needs more labels if the authors want it to be comprehensible.

7\) The reviewers suggest that the manuscript could benefit from tightening the Discussion in some places and expanding it in others. The Introduction is perhaps overly long, several sections of the Results should really have been placed in the Methods section, and a clear presentation of gaps from their previous 2014 paper that the present work fills will make this a more scholarly contribution.

8\) The map-to-model validations are incorrect. Why is the FSC between map and model taken at a threshold value of \~0.3 (providing a resolution of \~1/0.26 or \~3.8Å in B and \~1/0.28 or \~3.6Å in F). The correct criterion for the threshold should be 0.5 (see Rosenthal and Henderson 2003). According to the correct criterion, the map-to-model resolution is \~1/0.24 or \~4.2Å in B and \~1/0.26 or 3.8Å in E. Thus, the authors should validate the derived model, for example by performing a cross-validation analysis, similar to that described in Amunts et al. 2014 (from the authors\' own laboratory), or by other means.

9\) Along the same lines, it would be good to show how well the components of interest correspond to the experimental density, in addition to the full map/model. These could include: (1) local resolution of the CrPV-IRES and eEF2 components; (2) segmented 1/2-map experimental FSC curves and (3) map-to-model FSC curves of CrPV-IRES and eEF2.

10.7554/eLife.13567.023

Author response

Essential revisions:

*A major concern is that interpretation of the structures is underdeveloped in light of what is known. What is disappointing is the lack of connecting the structure to mechanistic topics of general interest to the IRES community. But that requires a deeper and more insightful analysis than is present in the manuscript. Consistent with this, there are key references missing (including many recent ones) that must be considered in the analysis. Several examples are given below:*

*In the last paragraph of the subsection "CrPV-IRES interaction with the isolated 40S ribosomal subunit". It was not clear what in this analysis of the interactions between the base-pairs of the codon-anticodon interaction and the ribosome is different than what has been described in other structures, including Koh et al. (2014) PNAS 11:9139-44, and previous work by these same authors in Fernandez et al. (2014) Cell 157:823-31. Perhaps this higher resolution work refines those interactions or makes them more certain. If something is truly novel here, the authors need to point it out. Otherwise, focus on the more novel potential findings that may lead to new ideas.*

Please see our combined responses to the first two comments immediately after the second comment.

*One very interesting and novel finding is the base-pair between C1273 and the first nt in the first decoded codon. But, the authors leave it as perhaps contributing to a \"productive conformation in the decoding center.\" This is not tested experimentally. In fact, the potential of this nt to form a base-pair within the IRES itself has been linked to the ability of some type IV IRESs to initiate in an alternate reading frame, thus this observation may have very exciting implications for IRES regulation (References: Au et al. (2015) PNAS 112:E6446-55; Wang et al. (2014) PloS One 9:e103601; Ren et al. (2012) PNAS 109:E630-9; Ren et al. (2014) Nucleic Acids Res. 42:9366-82.) None of these references, all with direct relationship to this structure, are included. Here and in a few other places, the manuscript (as written) does not reflect the current state of the field.*

We are grateful to the referees in bringing to our attention the relevant references mentioned above. Indeed, extensive mutagenesis and biochemical analysis involving base number one from the first coding codon helps substantially in clarifying the possible mechanism of frame-selection by these types of IRES sequences. We have now added a paragraph in the Results as well as in the Discussion section describing the possible role for the observed base pair established between C1273 and base one of the first codon of the IRES (termed BP4). Relevant references have been included.

*A missed opportunity: the interactions between the highly conserved apical loops of SL IV and V are known to make critical interactions with eS5 and eS25, but no high-resolution information is known for these interactions. Resolving this key mystery that would be a major contribution. [Figure 7](#fig7){ref-type="fig"}/[Video 1](#media1){ref-type="other"} -- The text and the model in [Figure 7](#fig7){ref-type="fig"} describe SL IV and V as not changing position between the eEF2 unbound to bound state. But, the movie shows something very different. How does the IRES achieve this non-canonical binding and how do the interactions change as the IRES moves? Other than stating an observation about their global position and not much movement occurring, the authors leave this unexplored. The authors miss an opportunity to examine how the Type IV IRESs and possibly other IRESs use these interactions. This is particularly interesting give the literatures regarding eS25 is pretty much as a central player in translation from many IRESs (Thompson lab, in particular).*

The overall resolution of the reconstructions are 3.8Å and 3.6Å. However, because the IRES is highly dynamic, the resolution for its elements shows great local resolution variation. We could confidently trace the RNA backbone as well as fitting the PKI domain solved at high resolution by X-ray crystallography (Costantino et al., NSMB, 2008), but the inherent flexibility of the IRES precluded an interpretation of individual interactions of the RNA bases of the IRES with ribosomal proteins. In order to illustrate the quality of the density, several movies with the experimental density for the SL-IV and SL-V as well as the PKI of the IRES in the 40S-complex are contributed as supplementary material ([Videos 2](#media2){ref-type="other"}, [3](#media3){ref-type="other"} and [4](#media4){ref-type="other"}).

What is the VLR loop in PKI doing in this mid-translocating state and how does it compare to the pre- and post-translocated state? [Video 1](#media1){ref-type="other"} shows some new density appearing at the junction between PKI and PKII upon eEF2 binding. It looks like the authors have modeled it as part of PKI\'s VLR. It is hard to tell from the movie/any figures. Recent work implicates this loop in elongation factor 2 function -- Ruehle et al., (2015) eLife --, and it has been explored in manuscripts from the Jan lab. What it is this loop doing and contacting and does it explain this previous work? Are previous predictions about its possible role correct?

We thank the reviewers for drawing our attention to the relevant references regarding the VRL. We saw partial density for the VLR in the context of CrPV-IRES/40S reconstruction (new [Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}), which, we speculate, could be related to the early recruitment events of the IRES to the 40S. However, in the reconstruction involving the 80S/CrPV/eEF2 complex the absence of density clearly suggests a disordered VRL at this stage. We added a paragraph in the Results section as well as in the Discussion focusing on how the VLR could play a role in the initial binding of the IRES to the 40S and how our results could be integrated in the previous body of knowledge regarding this specific element of the IRES. Relevant references have also been included.

In the last paragraph of the subsection "Overall architecture of a complex of CrPV-IRES with the ribosome and elongation factor eEF2". The position of the L1 stalk is interesting, but this is left with no explanation of potential significance. What might this say about how the IRES works? It is left as just an observation with no context. L1 is well established as a key player in translocation, so what does this odd position suggest? How does this fit into the idea of allosteric communication between L1 and other parts of the ribosome and bound factors? Are eukaryotes just different and what we have learned from bacteria does not apply?

A short paragraph has been added in the Discussion section on the putative role of the dynamics of the L1-stalk in type IV IRES-mediated translation. A definitive answer to these questions will require further biochemical and other studies. We hope that this paper will stimulate experimental approaches (like single-molecule FRET) to shed light on the function of this highly mobile element of the ribosome, as has occurred for bacterial translocation.

Can the authors say anything about conformational changes within the IRES, outside of PK I? Looking at some modeling from Yamamoto et al., 2, it would seem the larger part of the IRES may need to move or change structure, a bit for PK I to shift to its new location with the elongation factor. Some discussion of the overall movement of the IRES, and mechanistic implications, is needed.

We saw no additional major conformational changes in the IRES apart from the displacement of the PKI (as shown in [Figure 3C](#fig3){ref-type="fig"}). A superposition of the RNA backbone of the rest of CrPV-IRES (i.e. excluding PKI) in the pre-translocated state and in the presence of eEF2/GDPCP shows an r.m.s.d of 1.8Å. Thus, there may be subtle changes in the rest of the IRES; however, if they exist, it is not possible to characterize them definitely at this resolution.

*The position of PKI between the A and P sites was previously suggested or observed in the very first cryo-EM reconstructions of a type IV IRES bound to a ribosome (Spahn Lab). While this was of lower resolution, this previous observation should be acknowledged and discussed. The same is true of the conformational change in the 40S subunit that likely prepares it for 60S subunit binding.*

The first visualization of the CrPV-IRES in the context of the 40S and the 80S was achieved in Joachim Frank's lab (Spahn-Cell-2004) and is appropriately cited in our manuscript. A second, higher resolution, reconstruction for a CrPV/80S complex was reported from the Spahn lab in 2006 (Schuler-NSMB-2006, also cited in our manuscript), which we believe is the reference to which the reviewer is referring. In this 2006 reconstruction, the density for the PKI is highly disordered and the authors placed it "around the P and A sites". It is important to note that this reconstruction represents a pre-translocated, binary 80S/CrPV-IRES state. In contrast to the Schuler et al. 2006 paper, we and others (Fernandez-Cell-2014, Koh-PNAS-2014) have shown that in the pre-translocated complex, PKI is placed in the A site. It is only upon the action of eEF2 (as in this manuscript) that it occupies a well-defined intermediate state between A and P sites. It is thus our opinion that crediting Schuler-NSMB-2006 as the first reference where PKI was suggested or observed in-between the A and P sites would be misleading. The many other contributions from the Spahn lab are recognized throughout our manuscript, especially the recent structure of a post-translocated state that has been very useful for our analysis of the structures.

In regard to the observations relating to the diphthamide modification: this is an interesting result and one that bears deeper discussion. The authors suggest that the diphthamide on allows IRES-specific manipulation of the translation machinery that promotes translocation. But the region of the IRES that diphthamide contacts is the most similar to a canonical ribosome substrate in the entire IRES, begging the question of why there would need to be an IRES-specific solution there. Furthermore, there is no discussion regarding what is known about how eEF2 contacts canonical tRNA substrates using this modification. Because ribosomal contacts must release the codon:anticodon minihelix in canonical initiation, and they can do so independently of the diphthamide modification ([Figure 5](#fig5){ref-type="fig"}), it suggests the ribosome already has mechanisms in place to do this that the IRES should be able to harness as well. If the authors are correct that the modification permits the first noncanonical translocation, would this suggest that there are other, endogenous messages that specifically need to use the diphthamide in a similar way (given its conservation energetic expense for the cell, 8 enzymes)?

We agree that the insights gained from the CrPV-IRES structures has relevance to the function of eEF2 in canonical translation. We propose that diphthamide aids in the similar re-orientation of the decoding bases A1753 and A1754 during canonical translation. While canonical translation can proceed efficiently in the absence of diphthamide, we propose that unique features of PKI and the unusual translocation required for CrPV IRES-mediated translation initiation makes the IRES translation more sensitive than canonical translation to loss of diphthamide. Rather than suggesting, as the reviewers do, that certain cellular mRNAs might use diphthamide in the same way as the CrPV-IRES, we prefer a model in which diphthamide enhances fidelity at all translocation steps and that the unique features of the CrPV-IRES and its translocation confer a heightened requirement for diphthamide. In accord with this line of thinking, we prefer to not speculate that some cellular mRNAs might be translated in a manner similar to the translocation mechanism employed by the CrPV IRES.

Three previous cryo-EM studies have provided modest insights into how diphthamide contacts canonical tRNA translocation substrates. Christian Spahn and Joachim Frank published a low-resolution structure of eEF2 on the 80S ribosome (EMBO J 23:1008-1019 (2004)). Notably, the structure did not contain tRNAs, and instead tRNAs were modeled in. In the model, diphthamide was positioned near the codon:anticodon duplex, and the authors speculated that diphthamide might functionally replace A1492/A1493 to stabilize the codon-anticodon pairing during translocation (they did not consider the idea that diphtamide might help break the decoding interaction). In a follow-up paper by Derek Taylor (EMBO J 26:2421-2431 (2007)), the structure of ADP-ribosylated eEF2 on the 80S was examined. This second paper focused on the impact of GTP hydrolysis by eEF2 and on eEF2 and ribosome conformations. The interaction of eEF2 and diphthamide with tRNA was not discussed; however, it was proposed that movement of the tip of domain IV of eEF2 during GTP hydrolysis might disrupt the interaction of the decoding center with the mRNA-tRNA duplex. Finally, Beckmann and colleagues reported the structure eEF2 bound to *Drosophila* and human ribosomes. Notably, these complexes contained an E-site tRNA and the protein SERBP1 (similar to Stm1 of yeast) snaking through the mRNA channel and the A and P sites of the 80S. The diphthamide moiety on eEF2 adopted two positions in these structures: 1) engaging helix 44 near the decoding bases, or 2) engaging SERBP1 in the mRNA channel. As these structures lack A- and P-site tRNAs, they do not provide insights into how diphthamide interacts with the translocation substrate. Thus, our structure provides the first image of eEF2 and diphthamide interacting with an authentic substrate on the ribosome.

We have edited the text in the Discussion to include these ideas.

Other important points:

The Discussion section seems to largely repeat what was stated in the Results, without adding much insight.

*1) [Figure 1](#fig1){ref-type="fig"} -- This is essentially the only place where the map of the 40S/CrPV-IRES structure is shown (except for the representation in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} for resolution estimation). The way that it is displayed does not allow the reader to see how complete the structure is, nor how well the model fits to the structure. In D, the authors are obviously using space-filled models for the interactions -- actual density for these regions would allow the reader to see if these models actually are supported by the data in those regions.*

We added a panel with the experimental density for the decoding elements of the 40S in the presence of CrPV-PKI (B, left panel). In order to be consistent with the original high resolution structural paper on decoding (Ogle-Science-2001), we feel it is better to display the base pairs as space-filling models, because they are derived from a stereo-chemically-correct, refined model. However, we changed the figure legend to clearly reflect this and avoid misinterpretation; we also show the experimental density in [Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"} and [Video 2](#media2){ref-type="other"}.

2\) [Figure 2](#fig2){ref-type="fig"} -- As with [Figure 1](#fig1){ref-type="fig"}, the size and method of displaying the model for the 80D/CrPV-IRES/eEF2 map and model does not allow the reader or reviewer to judge the quality of fit or completeness of the map. Is A the map or model? B appears to be much lower resolution; is this the map? The authors should clearly indicate what they are showing (and should show the density when possible).

We used space-filling models for the CrPV and eEF2 in panel A as has been done in many papers describing structures of ribosomal complexes by X-ray crystallography at similar resolution, either from our group (Neubauer --Cell-2009, Gao-Science-2009) or from other groups (Zhou-Science-2014, Blaha-Science-2009). At this resolution an overall view with density would be very confusing so we decided to clarify in the figure legend what is shown and additionally we now include a movie with the experimental density for eEF2 ([Video 5](#media5){ref-type="other"}). The density for the L1-stalk is shown in [Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}. Additionally, all relevant computed maps as well as the refined models will be made publicly available.

3\) [Figure 3](#fig3){ref-type="fig"} --This is not well described; the authors need to find a better way to communicate what they are saying here.

To make interpretation of the figure easier for the reader, we have reorganized the panels and added connecting information between the panels. Also, labels for each panel have been added to make it easier to identify the components of each view.

To properly explain the positioning of the CrPV-IRES PKI, it was mandatory to isolate PKI from the rest of the model, otherwise the representation was very messy. We feel that using descriptions similar to those used previously to describe tRNAs in several configurations (canonical and hybrid) is a good idea given the structural similarity relating the PKI with a canonical tRNA/mRNA pair. Thus, we have chosen to use this type of representation (top view of the solvent side of the small subunit) in panel D to highlight the occupancy of the ribosomal A and P sites. This mode of representation is frequently used in the ribosome field (e.g. Selmer-Science-2006, [Figure 3](#fig3){ref-type="fig"}; Blaha-Science-2009, [Figure 5](#fig5){ref-type="fig"}; Zhou-Science-2014, [Figure 2](#fig2){ref-type="fig"}).

4\) [Figure 4](#fig4){ref-type="fig"} -- As in other figures, when making claims about \"clear density\" (see subsection "Interaction of domain IV of eEF2 with PKI and implications for translocation", first paragraph) for side-chains, that clear density needs to be shown. The authors display models in B-D but no density. Also, figures in E and F are unclear: are these models? Density? Of what?

We have replaced panel 4B with a close-up view of the area of interest that includes the experimental density. Additionally, we added a short movie with the experimental density for eEF2 ([Video 6](#media6){ref-type="other"}). We explicitly clarify in the figure legend that panels E-F display Van der Waals rendered volumes of the refined model. These images illustrate the incompatibility of the position of the decoding bases 1753 and 1754 in their outward configuration with the position we observe for the tip of domain IV of eEF2. The steric clash between these eEF2 and the decoding bases is illustrated in panel F where the 40S is depicted in a different color to emphasize the clash. We have expanded the figure legend and added more labels to aid the reader.

*5) [Figure 6](#fig6){ref-type="fig"} -- This is the only place in the text where density is shown, but the region being shown is unlabeled. Additional labels in 6A and 6C should be included for clarity. Also, B should show comparison density from that complex as well.*

Labels have been added for panels A and C. The density for panel B is shown in panel A as well as in [video 7](#media7){ref-type="other"}. In panel C two superposed complexes are depicted (70S/EF-Tu and 70S/EF-G). Showing density for these two complexes (determined by X-ray crystallography at different resolutions) would be very messy.

6\) The supplemental movie needs more labels if the authors want it to be comprehensible.

More labels have been added.

7\) The reviewers suggest that the manuscript could benefit from tightening the Discussion in some places and expanding it in others. The Introduction is perhaps overly long, several sections of the Results should really have been placed in the Methods section, and a clear presentation of gaps from their previous 2014 paper that the present work fills will make this a more scholarly contribution.

We have edited the text in several places to address this comment.

8\) The map-to-model validations are incorrect. Why is the FSC between map and model taken at a threshold value of \~0.3 (providing a resolution of \~1/0.26 or \~3.8Å in B and \~1/0.28 or \~3.6Å in F). The correct criterion for the threshold should be 0.5 (see Rosenthal and Henderson 2003). According to the correct criterion, the map-to-model resolution is \~1/0.24 or \~4.2Å in B and \~1/0.26 or 3.8Å in E. Thus, the authors should validate the derived model, for example by performing a cross-validation analysis, similar to that described in Amunts et al. 2014 (from the authors\' own laboratory), or by other means.

[Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} shows, for both reconstructions, FSC curves between half-maps independently computed as suggested in Scheres-NatMethods-2012 (the Gold Standard FSC) (A and E). In panels B and F three curves are shown: black line is the model-map FSC using the final map and the final refined model; red and blue lines correspond to the cross-validation analysis, as first proposed in Amunts et al., Science (2014). Perhaps the overlapping of the two curves precluded clear observation, but the requested analysis has been performed and is shown. The superposition of the blue and red curves highlights the absence of over-fitting of the refined model as explained in Brown et al., ActaCrystD (2015). We have expanded the figure legend to make this explicit. In the expanded figure legend we also explain that the vertical line represents the maximum resolution included in the refinement.

9\) Along the same lines, it would be good to show how well the components of interest correspond to the experimental density, in addition to the full map/model. These could include: (1) local resolution of the CrPV-IRES and eEF2 components; (2) segmented 1/2-map experimental FSC curves and (3) map-to-model FSC curves of CrPV-IRES and eEF2.

Local resolution maps for the ligands (CrPV-IRES and eEF2) are now shown in the [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} (panels C and G).

[^1]: Department of Biochemistry and Molecular Biophysics, Columbia University, New York, United States.
